I am a
Home I AM A Search Login

Papers of the Week

2021 Feb 17

Curr Pain Headache Rep



Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?


Chakravarthy K, Goel A, Jeha GM, Kaye A D, Christo PJ
Curr Pain Headache Rep. 2021 Feb 17; 25(2):12.
PMID: 33598816.


Therapeutic use, misuse, abuse, and diversion of controlled substances in managing chronic non-cancer pain remain a major concern for physicians, the government, payers, and patients. The challenge remains finding effective diagnostic tools that can be clinically validated to eliminate or substantially reduce the abuse of controlled prescription drugs, while still assuring the proper treatment of those patients in pain. Urine drug testing still remains an important means of adherence monitoring, but questions arise as to its relevance and effectiveness. This review examines the role of UDT, determines its utility in current clinical practice, and investigates its relevance in current chronic pain management.